Launchpad Therapeutics, Inc. — Form D
Launchpad Therapeutics, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2022-12-30. The offering totals $30.0M, of which $10.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-12-30
- Form: D
- Accession: 0001959206-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $30.0M
- Amount sold: $10.0M
- Remaining: $20.0M
- Investors: 3
- Date of first sale: 2022-12-09
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-469187
Issuer
- Name: Launchpad Therapeutics, Inc.
- CIK: 0001959206
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: ONE MAIN STREET, 14TH FLOOR, CAMBRIDGE, MA, 02142
- Phone: 617-252-0848
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Ali Behbahani | Director | Littleton, CO |
| Alexander Mayweg | Director | South San Francisco, CA |
| Anna Kohlmann | Executive Officer | CAMBRIDGE, MA |
| Alexander Mayweg | Executive Officer | South San Francisco, CA |
More